Integris Medtech IPO Review & Recommendations

Bookbuilding IPO | ₹[.] Cr | Listing at BSE, NSE |

IPO Recommendations (0 Reviews)

Review ByApplyMay ApplyNeutralAvoidNot Rated
Count00000
%00000

Integris Medtech IPO Peer Comparison

Integris Medtech Ltd. peer comparison with similar listed entities. (As on March 31, 2025)

Company NameEPS (Basic)EPS (Diluted)NAV (per share) (Rs)P/E (x)RoNW (%)P/BV RatioFinancial statements
Our Company5.825.73316.091.84Consolidated
Poly Medicure34.1334.11278.4656.0212.266.87Consolidated
Laxmi Dental6.076.0537.7153.9516.098.81Consolidated

Notes:

  1. Closing Price per share is closing price in NSE as on October 8, 2025.
  2. P/E has been computed as market price per share as on October 8, 2025 divided by net diluted earnings per share for the year ended March 31, 2025.
  3. Basic EPS (₹) = Basic earnings per share are calculated by dividing the net restated profit or loss for the year attributable to equity shareholders by the weighted average number of Equity Shares outstanding during the year.
  4. Diluted EPS (₹) = Diluted earnings per share are calculated by dividing the net restated profit or loss for the year attributable to equity shareholders by the weighted average number of Equity Shares outstanding during the year as adjusted for the effects of all dilutive potential Equity Shares outstanding during the year.
  5. Weighted average number of Equity Shares is the number of Equity Shares outstanding at the beginning of the year adjusted by the number of Equity Shares issued during the year multiplied by the time weighting factor. The time weighting factor is the number of days for which the specific shares are outstanding as a proportion of total number of days during the year.
  6. Return on Net Worth (%) = Net Profit after tax attributable to owners of our Company divided by net worth at the end of the respective year/ period as per the Restated Consolidated Financial Information.
  7. Net Worth is calculated as equity share capital plus other equity less capital reserves less common control adjustments deficit accounts and foreign currency translation reserve.
  8. Net Asset Value per Equity Share = Net worth in accordance with the Restated Consolidated Financial Information/ Weighted Average Number of equity shares outstanding for the purpose of calculation of basic EPS as of the end of the year.
  9. For our Company, all the numbers have been taken from Restated Consolidated Financial Information. For others, all the numbers have been sourced from the F&S Report.

IPO Review by Members

Integris Medtech IPO Reviews, analysis and views by popular members.

Post Manage

Review ByApplyMay ApplyNot RatedAvoid
Count0000
%0.000.000.000.00
MemberReview
No recommendation found. Be the first to post the recommendation.

  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.
Open an Instant Account with Zerodha